26
|
Delvino D, Sardanelli F, Cohen P, Puéchal X, Mouthon L, Guillevin L, Terrier B. Rémission et état de faible activité de la maladie chez les patients atteints de granulomatose avec polyangéite et polyangéite microscopique : prévalence et impact sur les séquelles à long terme. Rev Med Interne 2019. [DOI: 10.1016/j.revmed.2019.10.063] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
27
|
Puéchal X, Iudici M, Pagnoux C, Karras A, Cohen P, Maurier F, Quéméneur T, Lifermann F, Hamidou M, Mouthon L, Terrier B, Guillevin L. Rémission à distance de tout traitement au cours de la granulomatose avec polyangéite (Wegener) : données du registre du Groupe français d’étude des vascularites. Rev Med Interne 2019. [DOI: 10.1016/j.revmed.2019.10.061] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
28
|
Papo M, Sinico R, Teixeira V, Urban M, Mahrhold J, Monti S, Cassone G, Schiavon F, Seeliger B, Neumann T, Kroegel C, Groh M, Samson M, Jayne D, Hellmich B, Salvarani C, Guillevin L, Emmi G, Vaglio A, Terrier B. La granulomatose éosinophilique avec polyangéite (Churg-Strauss) avec positivité des ANCA-PR3 existe-t-elle réellement ? Rev Med Interne 2019. [DOI: 10.1016/j.revmed.2019.10.055] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
29
|
Puéchal X, Pagnoux C, Baron G, Lifermann F, Geffray L, Quéméneur T, Saraux J, Wislez M, Cottin V, Ruivard M, Limal N, Guillevin L. Suivi à long-terme des patients atteints de granulomatose éosinophilique avec polyangéite inclus dans l’étude CHUSPAN2 ayant évalué l’intérêt de l’adjonction de l’azathioprine à la corticothérapie en traitement d’induction. Rev Med Interne 2018. [DOI: 10.1016/j.revmed.2018.10.263] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
30
|
Henriquez S, Dunogué B, Régent A, Cohen P, Berezne A, Le Jeunne C, Mouthon L, Roux C, Guillevin L, Briot K, Terrier B. Le tissu adipeux abdominal prédit la survenue d’évènements cardiovasculaires majeurs au cours des vascularites nécrosantes : étude prospective de 120 patients. Rev Med Interne 2018. [DOI: 10.1016/j.revmed.2018.10.322] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
31
|
Papo M, Emmi G, Schiavon F, Groh M, Samson M, Kahn J, Sinico R, Puéchal X, Mouthon L, Guillevin L, Vaglio A, Terrier B. Caractéristiques au diagnostic et profils évolutifs des patients atteints de granulomatose éosinophilique avec polyangéite (Churg-Strauss) : données d’une étude rétrospective collaborative européenne. Rev Med Interne 2018. [DOI: 10.1016/j.revmed.2018.10.259] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
32
|
Mestiri R, Lafarge A, Puéchal X, Mouthon L, Guillevin L, Terrier B. Infections opportunistes au cours des vascularites nécrosantes primitives. Rev Med Interne 2018. [DOI: 10.1016/j.revmed.2018.10.317] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
33
|
Champtiaux N, Cottin V, Chassagnon G, Chaigne B, Valeyre D, Nunes H, Hachulla E, Launay D, Crestani B, Cazalets C, Jego P, Bussone G, Bérezné A, Guillevin L, Revel MP, Cordier JF, Mouthon L. Combined pulmonary fibrosis and emphysema in systemic sclerosis: A syndrome associated with heavy morbidity and mortality. Semin Arthritis Rheum 2018; 49:98-104. [PMID: 30409416 DOI: 10.1016/j.semarthrit.2018.10.011] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2017] [Revised: 09/10/2018] [Accepted: 10/09/2018] [Indexed: 12/11/2022]
Abstract
BACKGROUND The syndrome of combined pulmonary fibrosis and emphysema (CPFE) primarily due to tobacco smoking has been reported in connective tissue disease, but little is known about its characteristics in systemic sclerosis (SSc). METHODS In this retrospective multi-center case-control study, we identified 36 SSc patients with CPFE, and compared them with 72 SSc controls with interstitial lung disease (ILD) without emphysema. RESULTS Rate of CPFE in SSc patients with CT scan was 3.6%, and 7.6% among SSc patients with ILD. CPFE-SSc patients were more likely to be male (75 % vs 18%, p < 0.0001), smokers (83 % vs 33%, p < 0.0001), and to have limited cutaneous SSc (53 % vs 24% p < 0.01) than ILD-SSc controls. No specific autoantibody was significantly associated with CPFE. At diagnosis, CPFE-SSc patients had a greater decrease in carbon monoxide diffusing capacity (DLCO 39 ± 13 % vs 51 ± 12% of predicted value, p < 0.0001) when compared to SSc-ILD controls, whereas lung volumes (total lung capacity and forced vital capacity) were similar. During follow-up, CPFE-SSc patients more frequently developed precapillary pulmonary hypertension (PH) (44 % vs 11%, p < 10-4), experienced more frequent unscheduled hospitalizations (50 % vs 25%, p < 0.01), and had decreased survival (p < 0.02 by Kaplan-Meier survival analysis) as compared to ILD-SSc controls. CONCLUSIONS The CPFE syndrome is a distinct pulmonary manifestation in SSc, with higher morbidity and mortality. Early diagnosis of CPFE by chest CT in SSc patients (especially smokers) may result in earlier smoking cessation, screening for PH, and appropriate management.
Collapse
|
34
|
Roux GL, Wautier MP, Guillevin L, Wautier JL. IgG Binding to Endothelial Cells in Systemic Lupus Erythematosus. Thromb Haemost 2018. [DOI: 10.1055/s-0038-1661628] [Citation(s) in RCA: 28] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Abstract
SummaryEndothelial-asSociated IgG were determined in 20 patients with systemic lupus erythematosis (SLE) - 8 of whom had a lupus anticoagulant (LA) and 6 a history of thrombosis. The binding of IgG present in patient plasma to cultured human endothelial cells was detected using radiolabeled staphylococcal protein A. Thirteen samples gave positive results and a significant association between endothelial-associated IgG and lupus anticoagulant was found (p <0.05). No statistically significant relationship with a previous history of thrombosis was found. These results suggest that the lupus anticoagulant may be directly involved in immune vascular injury induced by either antibodies or immune complexes in SLE.
Collapse
|
35
|
Maillet T, Goletto T, Dupuy H, Jouneau S, Cottin V, Devilliers H, Lazaro E, Bonniaud P, Puéchal X, Guillevin L, Terrier B, Samson M. Fibrose pulmonaire au cours des vascularites associées aux ANCA : un facteur pronostique. Rev Med Interne 2018. [DOI: 10.1016/j.revmed.2018.03.318] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
36
|
Fauvelle F, Leon A, Niakate M, Petitjean O, Guillevin L. Pharmacokinetics of Paracetamol, Diclofenac and Vidarabine during Plasma Exchange. Int J Artif Organs 2018. [DOI: 10.1177/039139888801100313] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
In order to establish guidelines for prescribing drugs in patients treated with plasma exchange (PE), we studied the pharmacokinetics of paracetamol (5 patients), diclofenac (4 patients) and vidarabine (3 patients) during one or several PE. Results were compared with those obtained without PE. Diclofenac and paracetamol were choosen because they presented different volume distribution and protein binding characteristics. Vidarabine was studied because we use it for the treatment of patients with polyarteritis nodosa related to hepatitis B virus. Diclofenac (100 mg) and paracetamol (1000 mg) were given 1 hour before PE. Samples were obtained 60 and 30 min before PE, every 15 min during PE and hourly for 2 hours after the end of PE. Vidarabine was given in continuous infusion, 15 mg/kg/d during the first week of treatment and 7.5 mg/kg/d during subsequent weeks. Samples were obtained before PE, 3 times during PE and every 30 min for 4 hours after the end of PE. Paracetamol, diclofenac, vidarabine and hypoxanthine arabinoside were assayed by high performance liquid chromatography. During each PE 60 ml/kg were removed and replaced by albumin. We found that 17% of diclofenac, 4.3% of paracetamol and 4.9% of vidarabine were removed during each session. Plasmapheresis clearance was 51% of plasma clearance for diclofenac, 15% for paracetamol and 10% for vidarabine. Drugs which are mainly removed during PE are those which are bound to proteins with a small distribution volume. Those drugs, such as diclofenac, must be administered after the end of each PE session. Drugs which present a large distribution volume and low protein binding can be given before the session. Vidarabine can be administered during PE without loss of effectiveness due to drug removal.
Collapse
|
37
|
Guillevin L, Amoura Z, Merviel P, Pourrat J, Bussel A, Sobel A, Khuy T, Houssin A, Alcalay D, Stroumza P, Sanderson F, Levy G, Frey G, Ang K. Treatment of Progressive Systemic Sclerosis by Plasma Exchange: Long-term Results in 40 Patients. Int J Artif Organs 2018. [DOI: 10.1177/039139889001300213] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
The efficacy of plasma exchanges (PE) during the course of scleroderma has only been investigated for short periods. The aim of this study was to follow patients over a long enough period to observe the course of the clinical and paraclinical symptoms in the short, medium, and long term. Forty patients, 24 women and 16 men, were treated by PE and observed for 1–3, 3–12 and over 12 months. Immunological, biological and clinical course and any undesirable side effects were evaluated using a detailed questionnaire. Concomitant therapies were reported and most frequently consisted of corticosteroids, colchicine, factor XIII or vasodilators (nifedipine, captopril). The therapeutic effectiveness of PE was assessed on the basis of improvements in cutaneous, digestive, joint, muscular, lung, cardiovascular and renal lesions. Our findings confirmed the effectiveness of short-term PE on scleroderma (52% of the patients improved during the first 3 months). However, this improvement was transient (5% improvement between 3 and 12 months and only 2.5% over 12 months) and limited to the cutaneous and muscular lesions. Thus, PE cannot be recommended for the treatment of progressive systemic sclerosis.
Collapse
|
38
|
Guillevin L, Leon A, Levy Y, Bletry O, Gayraud M, Andreu G, Godeau P. Treatment of Progressive Systemic Sclerosis with Plasma Exchange. Seven Cases. Int J Artif Organs 2018. [DOI: 10.1177/039139888300600608] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Seven patients, 4 women and 3 men afflicted with severe progressive systemic sclerosis (PSS) were treated with Plasma Exchange after failure of different other treatment. All patients presented Raynaud phenomenon and arthritis, 6 patients presented extensive skin lesions, 5 of them digestive manifestations, 3 pulmonary fibrosis. In one case PSS was associated with polymyositis, one patient presented bilateral recurrent cornea ulcerations, (Sjögren Syndrom) and one patient numerous skin ulcerations. In 5 patients adjuvant corticosteroid therapy was given during the course of PE. In 3 patients PE must be stopped after one or two sessions because of insufficient venous access. Among the 4 other patients 8 to 20 PE were performed: the patient with cornea ulcerations became blind during the treatment, skin ulcerations and severe Raynaud phenomenon did not improved in two other patients. Benefit of PE was noted in only one patient with regressive myositis, and improvement of articular and cutaneous symptoms. Therefore, PE are not useful in most patients afflicted with PSS, they are difficult to realize in numerous patients and did not improve clinical symptoms in most cases.
Collapse
|
39
|
Chilles M, Lhote R, Brillet P, Groh M, Puechal X, Cohen-Aubart F, Delbre X, Guilpain P, Barda T, De Boysson H, Duhaut P, Dominique S, Hachulla E, Hamidou M, Subra J, Lifermann F, Fain O, Cohen P, Lhote F, Nunes H, Mathian A, Catherinot E, Terrier B, Le Quellec A, Legendre C, Cottin V, Amoura Z, Couderc L, Diot E, Guillevin L, Tcherakian C. Impact des dilatations des bronches sur les caractéristiques cliniques et le pronostic des vascularites à ANCA : résultats d’une série de 61 patients. Rev Mal Respir 2018. [DOI: 10.1016/j.rmr.2017.10.107] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
40
|
Jardel S, Puéchal X, Le Quellec A, Groh M, Hamidou M, Maurier F, Aumaître O, Aouba A, Quéméneur T, Maucort-Boulch D, Guillevin L, Lega J. Mortalité dans les vascularites systémiques nécrosantes : une analyse rétrospective de la base de donnée/registre du Groupe français d’étude des vascularites. Rev Med Interne 2017. [DOI: 10.1016/j.revmed.2017.10.295] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
41
|
Puéchal X, Iudici M, Calich A, Vivot A, Terrier B, Regent A, Cohen P, Le Jeunne C, Mouthon L, Ravaud P, Guillevin L. Le rituximab comme traitement d’induction et d’entretien de la granulomatose avec polyangéite (Wegener). Étude de cohorte monocentrique de 114 patients. Rev Med Interne 2017. [DOI: 10.1016/j.revmed.2017.10.296] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
42
|
Grande M, Fernandez J, Dahmani B, Stanel S, Albin N, Guillevin L, Belorgey C, D'Andon A. How to assess a cancer therapy? Feedback from the French HTA body on the ESMO-MCBS. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx440.064] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
43
|
de Boysson H, Boulouis G, Parienti JJ, Touzé E, Zuber M, Arquizan C, Dequatre N, Detante O, Bienvenu B, Aouba A, Guillevin L, Pagnoux C, Naggara O. Concordance of Time-of-Flight MRA and Digital Subtraction Angiography in Adult Primary Central Nervous System Vasculitis. AJNR Am J Neuroradiol 2017; 38:1917-1922. [PMID: 28751515 DOI: 10.3174/ajnr.a5300] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2017] [Accepted: 05/20/2017] [Indexed: 11/07/2022]
Abstract
BACKGROUND AND PURPOSE 3D-TOF-MRA and DSA are 2 available tools to demonstrate neurovascular involvement in primary central nervous system vasculitis. We aimed to compare the diagnostic concordance of vessel imaging using 3D-TOF-MRA and DSA in patients with primary central nervous system vasculitis. MATERIALS AND METHODS We retrospectively identified all patients included in the French primary central nervous system vasculitis cohort of 85 patients who underwent, at baseline, both intracranial 3D-TOF-MRA and DSA in an interval of no more than 2 weeks and before treatment initiation. Two neuroradiologists independently reviewed all 3D-TOF-MRA and DSA imaging. Brain vasculature was divided into 25 arterial segments. Concordance between 3D-TOF-MRA and DSA for the identification of arterial stenosis was assessed by the Cohen κ Index. RESULTS Thirty-one patients met the inclusion criteria, including 20 imaged with a 1.5T MR unit and 11 with a 3T MR unit. Among the 25 patients (81%) with abnormal DSA findings, 24 demonstrated abnormal 3D-TOF-MRA findings, whereas all 6 remaining patients with normal DSA findings had normal 3D-TOF-MRA findings. In the per-segment analysis, concordance between 1.5T 3D-TOF-MRA and DSA was 0.82 (95% CI, 0.75-0.93), and between 3T 3D-TOF-MRA and DSA, it was 0.87 (95% CI, 0.78-0.91). CONCLUSIONS 3D-TOF-MRA shows a high concordance with DSA in diagnostic performance when analyzing brain vasculature in patients with primary central nervous system vasculitis. In patients with negative 3T 3D-TOF-MRA findings, the added diagnostic value of DSA is limited.
Collapse
|
44
|
Lafarge A, Pagnoux C, Puéchal X, Samson M, Hamidou M, Karras A, Quéméneur T, Groh M, Mouthon L, Ravaud P, Guillevin L, Terrier B. Complications onco-hématologiques au cours des vascularites nécrosantes : analyse poolée de 5 essais thérapeutiques prospectifs. Rev Med Interne 2017. [DOI: 10.1016/j.revmed.2017.03.114] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
45
|
Berezne A, Abdoul H, Karras A, Bienvenu B, Imbert B, Marie I, Barbet C, Queyrel V, Bazin-Kara D, Kahn J, Mouthon L, Guillevin L. ScS REINBO : évaluation de l’efficacité du bosentan au cours de la crise rénale sclérodermique (CRS) en adjonction au traitement de référence comprenant un IEC ± autres anti-hypertenseurs. Rev Med Interne 2017. [DOI: 10.1016/j.revmed.2017.03.065] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
46
|
Lafarge A, Pagnoux C, Puéchal X, Samson M, Hamidou M, Karras A, Quéméneur T, Groh M, Mouthon L, Ravaud P, Guillevin L, Terrier B. Complications infectieuses au cours des vascularites nécrosantes : analyse poolée de 5 essais thérapeutiques prospectifs. Rev Med Interne 2017. [DOI: 10.1016/j.revmed.2017.03.112] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
47
|
Durel C, Hot A, Trefond L, Pugnet G, Samson M, Guillevin L, Terrier B. Pseudo-tumeurs inflammatoires orbitaires au cours des vascularites associées aux ANCA : étude rétrospective portant sur 57 patients. Rev Med Interne 2017. [DOI: 10.1016/j.revmed.2017.03.078] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
48
|
Delaval L, Schein F, Agard C, Aumaître O, Deroux A, Dupuy H, Garrouste C, Landron C, Maurier F, Cathébras P, Guillevin L, Terrier B. Artérites temporales révélant une vascularite associée aux ANCA : étude rétrospective portant sur 44 cas. Rev Med Interne 2017. [DOI: 10.1016/j.revmed.2017.03.097] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
49
|
Fournier A, Sultan A, Morello R, Hachulla E, Smail A, Verdon R, Launay O, Guillevin L, Bienvenu B, Marchand-Janssen C. DTPID : comment sont vaccinés les patients atteints d’une maladie inflammatoire systémique ? Med Mal Infect 2017. [DOI: 10.1016/j.medmal.2017.03.307] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
50
|
De Boysson H, Martin Silva N, De Moreuil C, Néel A, De Menthon M, Boutemy J, Maigné G, Guillevin L, Puéchal X, Bienvenu B, Aouba A. Les dermatoses neutrophiliques dans les vascularites associées aux ANCA. Rev Med Interne 2016. [DOI: 10.1016/j.revmed.2016.10.062] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|